Biotronik, a manufacturer of implantable cardiac devices and wireless remote monitoring technologies, has been added to the list of cardiac rhythm management (CRM) device suppliers to the U.S. Department of Veterans Affairs (VA).


Advancements in technologies are paving the way for many healthcare providers to connect with patients outside their hospitals more quickly and efficiently. For cardiology departments, technologies that allow for video collaboration, rapid transmission of scans and images and other forms of telemedicine are supporting the initiative to improve productivity, an initiative many are striving for as the U.S. healthcare landscape continues reform.

At Johnston Medical Center in Smithfield N.C., StatVideo’s EchoCart streams real-time images of babies’ hearts and live video conferencing over the web to pediatric cardiologists at Duke Children’s Hospital. EchoCart is a telemedicine system designed specifically for tele-echocardiography.

Vascular Solutions Inc. launched the ThrombiDisc topical hemostat designed for use around indwelling lines up to 12°F. ThrombiDisc contains both the power of thrombin to facilitate hemostasis and the antimicrobial properties of silver. 

After several months of intense review and assessment of its specialized worker training program by an independent agency, Operon Resource Management of Lowell, Mass. received ISO 13485 certification.

A University of Utah-led study for treatment of patients with atrial fibrillation (A-fib) provides strong clinical evidence for the use of 3-D MRI to individualize disease management and improve outcomes. Results of the Delayed-Enhancement MRI Determinant of Successful Radio-frequency Catheter Ablation of Atrial Fibrillation (DECAFF) study will be published in the Journal of the American Medical Association.

eCardio Diagnostics is opening its second Independent Diagnostic Testing Facility (IDTF) in San Francisco, Calif. Its first IDTF is located in Houston, Texas. 

Results from several late breaking clinical trials will be presented during  the American College of Cardiology (ACC) 2014 annual meeting March 29-31. These will be featured during five late-breaking clinical trial sessions. 

Procyrion Aortix Ventricular Assist Device Hemodynamic Support Heart Failure

Start-up company Procyrion Inc. is developing a catheter-deployed circulatory assist device intended for long-term use in the treatment of chronic heart failure. The 6 mm diameter Aortix device is narrower than a pencil and is delivered via a catheter in a minimally invasive outpatient procedure lasting about 10 minutes.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now